Search Results
R-CHOP dose intensity and survival outcomes in DLBCL
Tailoring chemotherapy: R-CHOP dose attenuation in elderly DLBCL
Phase II trial of split-dose R-CHOP for older patients with DLBCL
Smart Stop: Moving away from R-CHOP in DLBCL
Should R-CHOP Remain the Standard of Care for DLBCL?
PET2-assoicated outcomes in patients with DLBCL
Relative dose intensity in older DLBCL patients
How the treatment landscape of DLBCL is changing: R-CHOP vs pola-R-CHP
REMoDL-B: bortezomib + R-CHOP versus R-CHOP in patients with DLBCL
Fracture risk in older DLBCL patients after R-CHOP
COALITION: glofitamab + R-CHOP or glofitamab + pola-R-CHP in high-risk DLBCL
DLBCL Which drugs can be combined with R CHOP HD